PMC:7417201 / 10060-12399
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T20 | 1492-1496 | Body_part | denotes | Body | http://purl.org/sig/ont/fma/fma256135 |
| T21 | 1542-1547 | Body_part | denotes | Chest | http://purl.org/sig/ont/fma/fma9576 |
| T22 | 2316-2331 | Body_part | denotes | coronary artery | http://purl.org/sig/ont/fma/fma49893 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T22 | 1542-1547 | Body_part | denotes | Chest | http://purl.obolibrary.org/obo/UBERON_0001443 |
| T23 | 2316-2331 | Body_part | denotes | coronary artery | http://purl.obolibrary.org/obo/UBERON_0001621 |
| T24 | 2325-2331 | Body_part | denotes | artery | http://purl.obolibrary.org/obo/UBERON_0001637 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T54 | 914-922 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T55 | 1083-1091 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T56 | 1591-1599 | Disease | denotes | Diabetes | http://purl.obolibrary.org/obo/MONDO_0005015 |
| T57 | 1737-1749 | Disease | denotes | Hypertension | http://purl.obolibrary.org/obo/MONDO_0005044 |
| T58 | 1790-1804 | Disease | denotes | Hyperlipidemia | http://purl.obolibrary.org/obo/MONDO_0021187 |
| T59 | 1896-1899 | Disease | denotes | CAD | http://purl.obolibrary.org/obo/MONDO_0005010|http://purl.obolibrary.org/obo/MONDO_0018922 |
| T61 | 2312-2315 | Disease | denotes | CAD | http://purl.obolibrary.org/obo/MONDO_0005010|http://purl.obolibrary.org/obo/MONDO_0018922 |
| T63 | 2316-2339 | Disease | denotes | coronary artery disease | http://purl.obolibrary.org/obo/MONDO_0005010 |
| T64 | 2325-2339 | Disease | denotes | artery disease | http://purl.obolibrary.org/obo/MONDO_0000473 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T82 | 207-211 | http://purl.obolibrary.org/obo/CLO_0001185 | denotes | 2018 |
| T83 | 347-349 | http://purl.obolibrary.org/obo/CLO_0001313 | denotes | 36 |
| T84 | 435-439 | http://purl.obolibrary.org/obo/CLO_0001185 | denotes | 2018 |
| T85 | 451-453 | http://purl.obolibrary.org/obo/CLO_0001302 | denotes | 34 |
| T86 | 584-589 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tests |
| T87 | 621-622 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T88 | 639-643 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test |
| T89 | 983-987 | http://purl.obolibrary.org/obo/CLO_0001185 | denotes | 2018 |
| T90 | 1156-1160 | http://purl.obolibrary.org/obo/CLO_0001185 | denotes | 2018 |
| T91 | 1417-1419 | http://purl.obolibrary.org/obo/CLO_0053733 | denotes | 11 |
| T92 | 1433-1435 | http://purl.obolibrary.org/obo/CLO_0053733 | denotes | 11 |
| T93 | 1441-1445 | http://purl.obolibrary.org/obo/UBERON_0003101 | denotes | Male |
| T94 | 1441-1445 | http://www.ebi.ac.uk/efo/EFO_0000970 | denotes | Male |
| T95 | 1542-1547 | http://www.ebi.ac.uk/efo/EFO_0000965 | denotes | Chest |
| T96 | 1565-1567 | http://purl.obolibrary.org/obo/CLO_0001302 | denotes | 34 |
| T97 | 1582-1584 | http://purl.obolibrary.org/obo/CLO_0001000 | denotes | 35 |
| T98 | 1767-1770 | http://purl.obolibrary.org/obo/CLO_0054060 | denotes | 102 |
| T99 | 1916-1918 | http://purl.obolibrary.org/obo/CLO_0001407 | denotes | 52 |
| T100 | 1978-1982 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test |
| T101 | 1999-2001 | http://purl.obolibrary.org/obo/CLO_0053733 | denotes | 11 |
| T102 | 2011-2013 | http://purl.obolibrary.org/obo/CLO_0053794 | denotes | 41 |
| T103 | 2033-2037 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test |
| T104 | 2092-2095 | http://purl.obolibrary.org/obo/CLO_0001377 | denotes | 462 |
| T105 | 2097-2099 | http://purl.obolibrary.org/obo/CLO_0001302 | denotes | 34 |
| T106 | 2105-2107 | http://purl.obolibrary.org/obo/CLO_0001313 | denotes | 36 |
| T107 | 2114-2116 | http://purl.obolibrary.org/obo/CLO_0001302 | denotes | 34 |
| T108 | 2161-2163 | http://purl.obolibrary.org/obo/CLO_0050509 | denotes | 27 |
| T109 | 2169-2172 | http://purl.obolibrary.org/obo/CLO_0001195 | denotes | 219 |
| T110 | 2174-2176 | http://purl.obolibrary.org/obo/CLO_0001407 | denotes | 52 |
| T111 | 2325-2331 | http://purl.obolibrary.org/obo/UBERON_0001637 | denotes | artery |
| T112 | 2325-2331 | http://www.ebi.ac.uk/efo/EFO_0000814 | denotes | artery |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T72 | 0-241 | Sentence | denotes | The number of stress SPECT-MPI studies performed during the pandemic (n = 123) was significantly lower (P < 0.0001) compared with the mean number of procedures in the corresponding months of the years 2017, 2018, and 2019 (n = 413) (Fig. 1). |
| T73 | 242-465 | Sentence | denotes | However, the percentage of abnormal stress SPECT-MPI studies was similar (P = 0.65) during the pandemic (36%) compared with mean percentage value of the corresponding months of the years 2017, 2018, and 2019 (34%) (Fig. 2). |
| T74 | 466-651 | Sentence | denotes | Of note, given the mean number of 139 abnormal stress SPECT-MPI in the previous 3 years and the number of 44 abnormal tests during the pandemic, there was a 68% of abnormal test missed. |
| T75 | 652-771 | Sentence | denotes | Baseline characteristics of the entire population according to the year of SPECT-MPI execution are reported on Table 1. |
| T76 | 772-851 | Sentence | denotes | Most of the considered variables were comparable between the two study periods. |
| T77 | 852-1020 | Sentence | denotes | Fig. 1 Number of stress SPECT-MPI procedures performed during COVID-19 pandemic and during corresponding months of the years 2017, 2018, and 2019 (P for trend < 0.0001) |
| T78 | 1021-1171 | Sentence | denotes | Fig. 2 Prevalence of abnormal stress SPECT-MPI studies during COVID-19 pandemic and during the corresponding months of the years 2017, 2018, and 2019. |
| T79 | 1172-1246 | Sentence | denotes | The percentage of abnormal stress SPECT-MPI studies was similar (P = 0.65) |
| T80 | 1247-1340 | Sentence | denotes | Table 1 Baseline characteristics of overall population according to the year of MPI execution |
| T81 | 1341-1399 | Sentence | denotes | All (n = 1361) 2020 (n = 123) 2017–2019 (n = 1238) P value |
| T82 | 1400-1440 | Sentence | denotes | Age (years) 64 ± 11 64 ± 10 64 ± 11 0.14 |
| T83 | 1441-1491 | Sentence | denotes | Male gender, n (%) 439 (32) 29 (24) 410 (33) < .05 |
| T84 | 1492-1541 | Sentence | denotes | Body mass index (kg/m2) 29 ± 5 29 ± 5 29 ± 6 0.43 |
| T85 | 1542-1590 | Sentence | denotes | Chest pain, n (%) 468 (34) 37 (30) 431 (35) 0.29 |
| T86 | 1591-1637 | Sentence | denotes | Diabetes, n (%) 437 (32) 47 (38) 390 (32) 0.12 |
| T87 | 1638-1683 | Sentence | denotes | Dyspnea, n (%) 624 (46) 49 (40) 575 (46) 0.16 |
| T88 | 1684-1736 | Sentence | denotes | Family history, n (%) 729 (54) 60 (49) 669 (54) 0.26 |
| T89 | 1737-1789 | Sentence | denotes | Hypertension, n (%) 1070 (79) 102 (83) 968 (78) 0.22 |
| T90 | 1790-1842 | Sentence | denotes | Hyperlipidemia, n (%) 949 (70) 92 (75) 857 (69) 0.20 |
| T91 | 1843-1889 | Sentence | denotes | Smoking, n (%) 416 (31) 26 (21) 390 (32) < .05 |
| T92 | 1890-1937 | Sentence | denotes | Known CAD, n (%) 593 (44) 52 (42) 541 (44) 0.76 |
| T93 | 1938-1957 | Sentence | denotes | Stress type < .0001 |
| T94 | 1958-2014 | Sentence | denotes | Physical exercise test, n (%) 519 (38) 11 (9) 508 (41) |
| T95 | 2015-2071 | Sentence | denotes | Pharmacological test, n (%) 842 (62) 112 (91) 730 (59) |
| T96 | 2072-2122 | Sentence | denotes | Abnormal MPI, n (%) 462 (34) 44 (36) 418 (34) 0.65 |
| T97 | 2123-2182 | Sentence | denotes | Total perfusion defect > 10% 246 (53) 27 (61) 219 (52) 0.26 |
| T98 | 2183-2277 | Sentence | denotes | Values are expressed as mean value ± standard deviation or as number (percentage) of subjects. |
| T99 | 2278-2339 | Sentence | denotes | MPI myocardial perfusion imaging, CAD coronary artery disease |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T12 | 1542-1552 | Phenotype | denotes | Chest pain | http://purl.obolibrary.org/obo/HP_0100749 |
| T13 | 1638-1645 | Phenotype | denotes | Dyspnea | http://purl.obolibrary.org/obo/HP_0002094 |
| T14 | 1737-1749 | Phenotype | denotes | Hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
| T15 | 1790-1804 | Phenotype | denotes | Hyperlipidemia | http://purl.obolibrary.org/obo/HP_0003077 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 135 | 914-922 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 137 | 1083-1091 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 146 | 1896-1934 | Gene | denotes | CAD, n (%) 593 (44) 52 (42) 541 (44) 0 | Gene:730249 |
| 147 | 1548-1552 | Disease | denotes | pain | MESH:D010146 |
| 148 | 1591-1599 | Disease | denotes | Diabetes | MESH:D003920 |
| 149 | 1638-1645 | Disease | denotes | Dyspnea | MESH:D004417 |
| 150 | 1737-1749 | Disease | denotes | Hypertension | MESH:D006973 |
| 151 | 1790-1804 | Disease | denotes | Hyperlipidemia | MESH:D006949 |
| 152 | 1938-1944 | Disease | denotes | Stress | MESH:D000079225 |
| 153 | 2072-2084 | Disease | denotes | Abnormal MPI | MESH:C535740 |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T65 | 914-922 | SP_7 | denotes | COVID-19 |
| T66 | 1083-1091 | SP_7 | denotes | COVID-19 |
| T67 | 2017-2032 | CHEBI:52217;CHEBI:52217 | denotes | Pharmacological |
| T68 | 2282-2292 | UBERON:0002349 | denotes | myocardial |
| T69 | 2316-2331 | UBERON:0001621 | denotes | coronary artery |
| T50079 | 914-922 | SP_7 | denotes | COVID-19 |
| T44925 | 1083-1091 | SP_7 | denotes | COVID-19 |
| T52972 | 2017-2032 | CHEBI:52217;CHEBI:52217 | denotes | Pharmacological |